Osteopetrosis and osteoporosis: Two sides of the same coin

Human Molecular Genetics

Volumn 8, Issue 10, 1999, Pages 1839-1846

  Lazner, Francesca ^a   Gowen, Maxine ^b   Pavasovic, Durda ^a   Kola, Ismail ^a  

^a MONASH UNIVERSITY   (Australia)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN K;

ALBERS SCHOENBERG DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BONE DISEASE; BONE REMODELING; CELL FUNCTION; CONTROLLED STUDY; DOWN SYNDROME; GENE FUNCTION; GENE MUTATION; GENETIC ENGINEERING; HUMAN; HUMAN TISSUE; KNOCKOUT MOUSE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOPOROSIS; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

ANIMALS; BONE REMODELING; CATHEPSINS; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; DOWN SYNDROME; GLYCOPROTEINS; HUMANS; MICE; MICE, KNOCKOUT; MUTATION; OSTEOPETROSIS; OSTEOPOROSIS; OSTEOPROTEGERIN; PROTO-ONCOGENE PROTEIN C-ETS-2; PROTO-ONCOGENE PROTEINS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; REPRESSOR PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 0032853547     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/8.10.1839     Document Type: Review

References (69)

1. Eriksen, E.F. and Langdahl, B.L. (1997) The pathogenesis of osteoporosis. Horm. Res., 48 (suppl. 5), 78-82.
2. Heymann, D., Guicheux, J., Gouin, F., Passuti, N. and Daculsi, G. (1998) Cytokines, growth factors and osteoclasts. Cytokine, 10, 155-168.
3. Barrett, A.J. and Kirschke, H. (1981) Cathepsin B, cathepsin H and cathepsin L. Methods Enzymol., 80, 535-561.
4. Schneider, G.B., Relfson, M. and Nicolas, J. (1986) Pluripotent hematopoietic stem cells give rise to osteoclasts. Am. J. Anat., 177, 505-511.
5. Udagawa, N., Takahashi, N., Akatsu, T, Tanaka, H., Sasaki, T., Nishihara, T., Koga, T. Martin, T.J. and Suda, T. (1990) Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc. Natl Acad. Sci. USA, 87, 7260-7264.
6. Walker, D.G. (1975) Control of bone resorption by hematopoietic tissue: the induction and reversal of congenital osteopetrosis in mice through the use of bone marrow and splenic transplants. J. Exp. Med., 142, 651-663.
7. Gothlin, G. and Ericsson, J.L.E. (1976) The osteoclast: review of ultrastructure, origin and structure-function relationship. Clin. Orthop., 120, 201-231.
8. Marks, J.S.C. (1976) Osteopetrosis in the IA rat cured by spleen cells from a normal littermate. Am. J. Anal., 146, 331-338.
9. Marks, J.S.C., Seifert, M.F. and McGuire, J.L. (1984) Congenitally osteopetrotic (op/op) mice are not cured by transplants of spleen or bone marrow cells from normal litlermates. Metab. Bone Dis. Relat. Res., 5, 183.
10. Coccia, P.F., Krivit, W., Cervenka, J., Clawson, C. Kersey, J.H., Kim, T.H., Nesbit, M.E., Ramsay, N.K.C., Warkentin, P.I., Teitelbaum, S.L., Kahn, A.J. and Brown, D.M. (1980) Successful bone-marrow transplantation for infantile malignant osteopetrosis. N. Engl. J. Med., 302, 702-708.
11. Ballet, J., Griscelli, C., Courtris, C., Milhaud, C. and Maroteux, P. (1977) Bone marrow transplantation in osteopetrosis. Lancet, ii, 1137.
12. Sorell, M., Kapoor, N., Kirkpatrick, D., Rosen, J.R., Chaganti, R.S.K., Lopez, C., Dupont, B., Pollack, M.S., Terrin, B.N., Harris, M.B., Vine, D., Rose, J.S., Grossen, C., Lane, J., Good, R.A. and O'Reilly, R.J. (1981) Marrow transplantation for juvenile osteopetrosis. Am. J. Med., 70, 1280-1287.
13. Felix, R., Hofstetter, W. and Cecchini, M.G. (1996) Recent developments in the understanding of the pathophysiology of osteopetrosis. Eur. J. Endocrinol., 134, 143-156.
14. Marks, S.C.J. and McGuire, J.L. (1989) Primary bone cell dysfunction. II: Osteopetrosis. In Tam, J., Heershe, T. and Murray, T. (eds), Metabolic Bone Disease: Cellular and Tissue Mechanisms. CRC Press, Boca Raton, FL, pp. 49-61.
15. Lajeunesse, D., Busque, L., Menard, P., Brunette, M.G. and Bonny, I. (1996) Demonstration of an osteoblast defect in two cases of human malignant osteopetrosis. J. Clin. Invest., 98, 1835-1842.
16. Kanis, J.A., Melton, L.J., Christiansen, C., Johnston, C.C. and Khaltaev, N. (1994) The diagnosis of osteoporosis. J. Bone Miner. Res., 9, 1137-1141.
17. Hui, S., Slemenda, C.W. and Johnston, C.C. (1988) Age and bone mass as predictors of fracture in a prospective study. J. Clin. Invest., 81, 1804-1809.
18. Marks, J.S.C. and Lane, P.W. (1976) Osteopetrosis, a new recessive skeletal mutation on chromosome 12 of the mouse. J. Hered., 67, 11-18.
19. Marks, S.C., Seifert, M.F. and Lane, P.W. (1985) Osteosclerosis, a recessive skeletal mutation on chromosome 19 in the mouse. J. Hered., 76, 171-176.
20. Grynpas, M. (1993) Age and disease-related changes in the mineral of bone. Calcif. Tissue Int., 53, s57-s64.
21. Hertwig, P. (1942) Sechs neue Mutationen bei der Hausmaus in ihrer Bedeutung fur allgemeine Vererbungsfragen. Z. Menschl. Vererb. Konstitutionsl., 26, 1-19.
22. Cotton, W.R. and Gaines, J.F. (1974) Unerupted dentition secondary to congenital osteopetrosis in the Osborne-Mendel rat (38146). Proc. Soc. Exp. Biol. Med., 146, 554-561.
23. Greep, R.O. (1941) An hereditary absence of the incisor tooth. J. Hered., 32, 397.
24. Pearce, L.W.H. (1948) Hereditary osteopetrosis of the rabbit. J. Exp. Med., 88, 579.
25. Marks, S.C. (1977) Osteopetrosis in the toothless (tl) rat: presence of osteoclasts but failure to respond to parathyroid extract or to be cured by infusion of spleen or bone marrow cells from normal littermates. Am. J. Anat., 149, 289-297.
26. Wiktor-Jedrzejczak, W., Szczylik, C., Ratajczak, M.Z. and Ahmed, A. (1986) Congenital murine osteopetrosis inherited with osteosclerotic gene: hematological characterization. Exp. Hematol., 14, 819-826.
27. Walker, D.G. (1975) Bone resorption in osteopetrotic mice by transplants of normal bone marrow and spleen cells. Science, 190, 784-785.
28. Seifert, M.F., Popoff, S.N., Jackson, M.A., MacKay, C.A., Cielinski, M. and Marks, J.S.C. (1993) Experimental studies of osteopetrosis in laboratory animals. Clin. Orthop. Relat. Res., 294, 23-33.
29. Marks, S.C.J. (1984) Congenital osteopetrotic mutations as probes of the origin, structure and function of osteoclasts. Clin. Orthop. Relat. Res., 189, 239-263.
30. Henkel, G.W., McKerchner, S.R., Yamamoto, H., Anderson, K., Oshima, R.G. and Maki, R. (1996) PU.1 but not Ets-2 is essential for macrophage development from embryonic stem cells. Blood, 88, 2917-2926.
31. Soriano, P., Montgomery, C., Geske, R. and Bradley, A. (1991) Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell, 64, 693-702.
32. Scott, E.W., Simon, M.C., Anastasi, J. and Singh, H. (1994) Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science, 265, 1573-1577.
33. Johnson, R.S., Spiegelman, B.M. and Papaloannou, V. (1992) Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell, 71, 577-586.
34. Wang, Z.Q., Ovitt, C., Grigoriadis, A.E., Mohle-Steinlein, U., Ruther, U. and Wagner, E.F. (1992) Bone and haematopoietic defects in mice lacking c-fos. Nature, 360, 741-745.
35. Drake, F.H., Dodds, R.A., James, I.E., Connor, J.R., Debouck, C., Richardson, S., Lee-Rykaczewski, E., Coleman, L., Rieman, D., Barthlow, R., Hastings, G. and Gowen, M. (1996) Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J. Biol. Chem., 217, 12511-12516.
36. Garnero, P., Drake, F.H., Foged, N.T., Delmas, P.D. and Delaissé, J. (1997) The collagenolytic efficiency of osteoclast cathepsin K is unique amongst vertebrate proteinases. J. Bone Miner. Res., 12, s155.
37. Bossard, M.J., Tomaszek, T.A., Thompson, S.K., Amegadzie, B.Y., Hanning, C.R., Jones, C., Kurdyla, J.T., McNulty, D.E., Drake, F.H., Gowen, M. and Levy, M.A. (1996) Proteolytic activity of human osteoclast cathepsin K. J. Biol. Chem., 217, 12517-12524.
38. Gelb, B.D., Shi, G.P., Chapman, H.A. and Desnick, R.J. (1996) Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science, 273, 1236-1238.
39. Johnson, M.R., Polymeropoulos, M.H., Vos, H.L., Ortiz de Luna, R.I. and Francomano, C.A. (1996) A nonsense mutation in the cathepsin K gene observed in a family with pycnodysostosis. Genome Res., 6, 1050-1055.
40. Maroteux, P. and Lamy, M. (1962) La pycnodyssostose. Presse Med., 70, 999-1002.
41. Maroteux, P. and Lamy, M. (1965) The malady of Toulouse-Lautrec. J. Am. Med. Assoc., 191, 715-717.
42. Maroteux, P. (1995) Toulouse-Lautrec's diagnosis. Nature Genet., 11, 363-364.
43. Frey, J.B. (1995) What dwarfed Toulouse-Lautrec? Nature Genet., 10, 128-130.
44. Gowen, M., Lazner, F., Dodds, R., Field, J., Tavaria, M., Bertoncello, I., Drake, F., Zavarsek, S., Tellis, I., Hertzog, P., Debouck, C. and Kola, I. (1999) Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralisation. J. Bone Miner. Res., in press.
45. Saftig, P., Hunziker, E., Wehmeyer, O., Jones, S., Boyde, A., Rommerskirch, W., Moritz, J.D., Schu, P. and von Figura, K. (1998) Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc. Natl Acad. Sci. USA, 95, 13453-13458.
46. Elmore, S.M. and Virginia, R. (1967) Pycnodysostosis: a review. J. Bone Joint Surg., 49, 153-162.
47. Most, W., Van der Wee-Pals, L., Ederveen, A., Papapoulos, S. and Lowik, C. (1997) Ovariectomy and orchidectomy induce a transient increase in the osteoclastogenic potential of bone marrow cells in the mouse. Bone, 20, 27-30.
48. Norman, C.H.Jr and Dubowy, J. (1971) Pycnodysostosis with splenomegaly and anemia. N.Y. State J. Med., 71, 2419-2421.
49. Raisz, L.G. (1988) Local and systemic factors in the pathogenesis of osteoporosis. N. Engl. J. Med., 318, 818-828.
50. Inoaka, T., Bilbe, G., Ishibashi, O., Tezuka, K., Kumegawa, M. and Kokubo, T. (1995) Molecular cloning of a human cDNA for cathepsin K: novel cysteine proteinase predominantly expressed in bone. Biochem. Biophys. Res. Commun., 206, 89-96.
51. Rantakokko, J., Aro, H.T., Savontaus, M. and Vuorio, E. (1996) Mouse cathepsin K: cDNA cloning and predominant expression of the gene in osteoclasts and in some hypertrophying chondrocytes during mouse development. FEBS Lett., 393, 301-313.
52. Bromme, D. and Okamoto, K. (1995) Human cathepsin O2, a novel cysteine protease highly expressed in osteoclastomas and ovary. Molecular cloning, sequencing and tissue distribution. Biol. Chem. Hoppe-Seyler, 376, 379-384.
53. Votta, B.J., Levy, M.A., Badger, A., Bradbeer, J., Dodds, R.A., James, I.E., Thompson, S., Bossard, M., Carr, T., Connore, J.R., Tomaszek, T.A., Szewczuk, L., Drake, F., Veber, D. and Gowen, M. (1997) Peptide aldehyde inhibitors of cathepsin K inhibit bone resorption both in vitro and in vivo. J. Bone Miner. Res., 12, 1396-1406.
54. Mano, H., Yuasa, T., Kameda, T., Miyazawa, K., Nakamura, Y., Shiokawa, M., Mori, Y., Yamada, T., Mayata, K., Shindo, H., Azuma, H., Hakeda, Y. and Kumegawa, M. (1996) Mammalian mature osteoclasts as estrogen target cells. Biochem. Biophys. Res. Commun., 223, 637-642.
55. Mizuno, A., Amizuka, N., Irie, K., Murakami, A., Fujise, N., Kanno, T., Sato, Y., Nakagawa, N., Yasuda, H., Mochizuki, S.-I., Gomibuchi, T., Yano, K., Shima, N., Washida, N., Tsuda, E., Morinaga, T., Higashio, K. and Ozawa, H. (1998) Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. Biochem. Biophys. Res. Commun., 247, 610-615.
56. Jilka, R.L., Hangoc, G., Girasole, G., Passeri, G., Williams, D.C., Abrams, J.S., Boyce, B., Broxmeyer, B. and Manolagas, S.C. (1992) Increased osteoclast development after estrogen loss: mediation by interleukin 6. Science, 257, 88-91.
57. Jilka, R.L., Takahashi, K., Munshi, M., Williams, D.C., Robertson, P.K. and Manolagos, S.C. (1998) Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow: evidence for autonomy from factors released during bone resorption. J. Clin. Invest., 101, 1942-1950.
58. Tomkinson, A., Gevers, E.F., Wit, J.M., Reeve, J. and Noble, B.S. (1998) The role of estrogen in the control of rat osteoclyte apoptosis. J. Bone Miner. Res., 13, 1243-1250.
59. Shapiro, S., Kelly, J.P., Rosenberg, L., Kaufman, d.W., Helmrich, S.P., Rosenheim, N.B., Lweis, J.L.Jr, Knapp, R.C., Stolley, P.D. and Scottenfeld, D. (1985) Risk of localized and widespread endometrial cancer in relation to recent and discontinued use of conjugated estrogens. N. Engl. J. Med., 313, 969-972.
60. Silver, J.J. and Einhorn, T.A. (1995) Osteoporosis and aging. Clin. Orthop. Relat. Res., 316, 10-20.
61. Simonet, W.S., Lacey, D.L., Dunstan, C.R., Kelley, M., Chang, M.-S., Luthy, R., Nguyen, H.Q., Wooden, S., Bennett, L., Boone, T., Shimamoto, G., DeRose, M., Elliott, R., Colombero, A., Tan, H.-L., Trail, G., Sullivan, J., Davy, E., Bucay, N., Renshaw-Gegg, L., Hughes, T.M., Hill, D., Pattison, W., Campbell, P. and Boyle, W.J. (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell, 89, 309-319.
62. Keeling, J.W., Hansen, B.F. and Kjaer, I. (1996) Pattern of malformations in the axial skeleton in human trisomy 21 fetuses. Am. J. Med. Genet., 68, 466-471.
63. Center, J., Beange, H. and McElduff, A. (1998) People with mental retardation have an increased prevalence of osteoporosis - a population study. Am. J. Mem. Retard., 103, 19-28.
64. Sepulveda, D., Allison, D.B., Gomez, J.E., Kreibich, K., Brown, R.A., Pierson, R.N. and Heymsfeild, S.B. (1995) Bone spinal and pelvic bone mineral density among individuals with Down syndrome. Am. J. Ment. Retard., 100, 109-114.
65. Kola, I. and Hertzog, P.J. (1997) Animal models in the study of the biological function of genes on human chromosome 21 and their role in the pathophysiology of Down syndrome. Hum. Mol. Genet., 6, 1713-1727.
66. Kola, I. (1997) Simple minded mice. Nature Genet., 16, 8-9.
67. Kola, I. and Hertzog, P.J. (1998) Down syndrome and mouse models. Curr. Opin. Genet. Dev., 8, 316-321.
68. Sumarsono, S.H., Wilson, T.J., Tymms, M.J., Venter, D.J., Corrick, C.M., Kola, R., Lahoud, M.H., Papas, T.S., Seth, A. and Kola, I. (1996) Down syndrome like skeletal abnormalities in Ets2 transgenic mice. Nature, 379, 534-537.
69. Grunberg, A. (1935) A new sub-lethal colour mutation in the house mouse. Proc. R. Soc. Biol., 118, 321-342.